Bordetella bronchiseptica: a rare cause of meningitis

BMC Infect Dis. 2020 Dec 3;20(1):922. doi: 10.1186/s12879-020-05668-2.

Abstract

Background: Bordetella bronchiseptica is a gram-negative, obligate aerobic coccobacillus known to cause disease in domesticated animals and pets. In humans, B. bronchiseptica commonly leads to respiratory infections like pneumonia or bronchitis, and animal contact usually precedes the onset of symptoms.

Case presentation: We report a case of post-traumatic B. bronchiseptica meningitis without recent surgery in the setting of immunosuppression with a monoclonal antibody. Our case concerns a 77-year-old male with ulcerative colitis on infliximab who sustained a mechanical fall and developed a traumatic cerebrospinal fluid leak complicated by meningitis. He received meropenem then ceftazidime during his hospital course, and temporary neurosurgical drain placement was required. His clinical condition improved, and he was discharged at his baseline neurological status.

Conclusions: B. bronchiseptica is an unusual cause of meningitis that may warrant consideration in immunocompromised hosts with known or suspected animal exposures. To better characterize this rare cause of meningitis, we performed a systematic literature review and summarized all previously reported cases.

Keywords: Bordetella bronchiseptica; Emerging infections; Infliximab; Meningitis.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Animals
  • Anti-Bacterial Agents / therapeutic use*
  • Bordetella Infections / drug therapy*
  • Bordetella Infections / microbiology
  • Bordetella bronchiseptica / isolation & purification*
  • Ceftazidime / therapeutic use*
  • Cerebrospinal Fluid Leak / complications
  • Colitis, Ulcerative / drug therapy
  • Drainage / methods
  • Humans
  • Immunocompromised Host
  • Immunosuppressive Agents / therapeutic use
  • Infliximab / therapeutic use
  • Male
  • Meningitis / drug therapy*
  • Meningitis / etiology
  • Meningitis / microbiology
  • Meningitis / surgery*
  • Meropenem / therapeutic use*
  • Neurosurgical Procedures / methods
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Immunosuppressive Agents
  • Ceftazidime
  • Infliximab
  • Meropenem